Australian innovation move "misses real needs"
This article was originally published in Clinica
The Medical Industry Association of Australia (MIAA) has welcomed a Health and Medical Investment Fund established last week by the government to increase access to top-end health innovations and facilities. It warns, however, that the move fails to address medtech-funding needs and cannot replace the need to reform the system.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.